论文部分内容阅读
瘀血阻肺是形成胶固之痰从而导致哮喘反复不愈的根本原因，以攻进瘀血法，采用天地哮灵治疗哮喘５０例，总有效率９４％；而用博利康尼对照治疗３０例，总有效率为６０％。两组比较，有显著差异。对肺功能ＦＥＶ＿１％和ＰＥＦＲ作治疗前后测定，结果有显著改善。本方有逐瘀破血，缓中补虚之功，使之气顺、瘀消，肺气得以术降。其机理可能是通过改善微循环，改善缺氧，减轻粘膜水肿，降低气道高反应，抑制炎症反应，拮抗各种介质如血小板激活因子等，从而改善了气道通气功能。
Blood stasis and obstruction of the lungs are the root cause of the formation of stagnant sputum, which leads to repeated attacks of asthma. In order to attack the blood stasis method, 50 cases of asthma are treated with Tiandixiaoling and the total effective rate is 94%; while the control is treated with brilliconazole. The total effective rate is 60%. There are significant differences between the two groups. The pulmonary function FEV_1% and PEFR were measured before and after treatment, and the results were significantly improved. This side has broken blood and promotes the work of supplementing deficiency, so that it can be suffocated and dispelled, and lung gas can be reduced. The mechanism may be to improve airway ventilation by improving microcirculation, improving hypoxia, reducing mucosal edema, reducing airway hyperresponsiveness, inhibiting inflammatory response, and antagonizing various media such as platelet activating factor.